DOI: 10.12890/2020_001656

Co-infection with Influenza A and COVID-19

Authors

  • Venu Madhav Konala Department of Internal Medicine, Division of Medical Oncology, Ashland Bellefonte Cancer Center, Ashland, KY, USA
  • Sreedhar Adapa Department of Internal Medicine, Division of Nephrology, Adventist Medical Center, Hanford, CA, USA
  • Vijay Gayam Department of Medicine, Interfaith Medical Center, Brooklyn, NY, USA
  • Srikanth Naramala Department of Internal Medicine, Division of Rheumatology, Adventist Medical Center, Hanford, CA, USA
  • Subba Rao Daggubati Wise Health System, Decatur, TX, USA
  • Chetan Brahma Kammari Internal Medicine, Cape Fear Valley Hospital, Fayetteville, NC, USA
  • Avantika Chenna Phobe Putney Memorial Hospital, Medical College of Georgia, Albany, GA, USA

drvenumadhav@gmail.com

Keywords

Coronavirus, COVID-19, influenza, acute respiratory distress syndrome

Abstract

COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection.

View the entire article

Downloads

Published

2020-04-20

How to Cite

1.
Konala VM, Adapa S, Gayam V, Naramala S, Daggubati SR, Kammari CB, et al. Co-infection with Influenza A and COVID-19. EJCRIM [Internet]. 2020 Apr. 20 [cited 2026 Nov. 4];7(5). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1656

Most read articles by the same author(s)